CA2022420C - Escherichia coli vaccine - Google Patents

Escherichia coli vaccine Download PDF

Info

Publication number
CA2022420C
CA2022420C CA002022420A CA2022420A CA2022420C CA 2022420 C CA2022420 C CA 2022420C CA 002022420 A CA002022420 A CA 002022420A CA 2022420 A CA2022420 A CA 2022420A CA 2022420 C CA2022420 C CA 2022420C
Authority
CA
Canada
Prior art keywords
toxin
coli
strains
vaccine
flagella
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002022420A
Other languages
English (en)
French (fr)
Other versions
CA2022420A1 (en
Inventor
Johannes F. Van Den Bosch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Akzo NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo NV filed Critical Akzo NV
Publication of CA2022420A1 publication Critical patent/CA2022420A1/en
Application granted granted Critical
Publication of CA2022420C publication Critical patent/CA2022420C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0258—Escherichia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002022420A 1989-08-18 1990-08-01 Escherichia coli vaccine Expired - Lifetime CA2022420C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP89.202110.6 1989-08-18
EP89202110 1989-08-18

Publications (2)

Publication Number Publication Date
CA2022420A1 CA2022420A1 (en) 1991-02-19
CA2022420C true CA2022420C (en) 2000-03-28

Family

ID=8202455

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002022420A Expired - Lifetime CA2022420C (en) 1989-08-18 1990-08-01 Escherichia coli vaccine

Country Status (16)

Country Link
US (1) US5750115A (OSRAM)
EP (1) EP0413378B1 (OSRAM)
JP (1) JP3031561B2 (OSRAM)
KR (1) KR0177510B1 (OSRAM)
CN (1) CN1062605C (OSRAM)
AU (1) AU635062B2 (OSRAM)
CA (1) CA2022420C (OSRAM)
DE (1) DE69016129T2 (OSRAM)
DK (1) DK0413378T3 (OSRAM)
ES (1) ES2070266T3 (OSRAM)
GR (1) GR3015782T3 (OSRAM)
HU (2) HU210965B (OSRAM)
IL (1) IL95175A (OSRAM)
NZ (1) NZ234933A (OSRAM)
TW (1) TW204353B (OSRAM)
ZA (1) ZA906100B (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3871489D1 (de) * 1987-10-26 1992-07-02 Akzo Nv Impfstoff gegen e.coli-blutvergiftung bei gefluegel.
EP1011440A4 (en) * 1997-05-16 2003-08-06 Medical Defense Tech Llc VACCINE AGAINST THE CORE OF LIPOPOLYSACCHARIDES
US6749831B1 (en) * 1997-05-16 2004-06-15 Medical Defense Technology, Llc Vaccine against lipopolysaccharide core
EP1076567A4 (en) * 1998-05-15 2001-12-12 Mkb Invest Ltd Partnership COMPOSITION AND METHOD FOR IMMUNIZATION OF POULTRY
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
JP5085547B2 (ja) * 2005-08-30 2012-11-28 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション 生理活性ポリペプチドの細菌性送達
CN102905522A (zh) 2009-10-12 2013-01-30 新健康科学股份有限公司 用于从红细胞中除去氧的氧消耗装置和方法
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
JP6199557B2 (ja) 2009-10-12 2017-09-20 ニュー ヘルス サイエンシーズ、インク．Ｎｅｗ Ｈｅａｌｔｈ Ｓｃｉｅｎｃｅｓ， Ｉｎｃ． 酸素及び二酸化炭素の減損能力をもつ血液保存袋システム及び減損装置
US9005343B2 (en) 2010-05-05 2015-04-14 New Health Sciences, Inc. Integrated leukocyte, oxygen and/or CO2 depletion, and plasma separation filter device
WO2012027582A1 (en) 2010-08-25 2012-03-01 New Health Sciences Method for enhancing red blood cell quality and survival during storage
WO2012061731A1 (en) 2010-11-05 2012-05-10 New Health Sciences Irradiation of red blood cells and anaerobic storage
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
US8926980B2 (en) * 2011-07-11 2015-01-06 Camas Incorporated Compositions against bacterial toxins
PT2961269T (pt) 2013-02-28 2021-12-16 Hemanext Inc Dispositivo de depleção de gás para produtos sanguíneos
KR102701691B1 (ko) 2015-03-10 2024-08-30 헤마넥스트 인코포레이티드 산소 감소 1회용 키트, 장치 및 이의 사용 방법
KR102845950B1 (ko) 2015-04-23 2025-08-12 헤마넥스트 인코포레이티드 혐기성 혈액 저장 용기
WO2016187353A1 (en) 2015-05-18 2016-11-24 New Health Sciences, Inc. Methods for the storage of whole blood, and compositions thereof
KR102701687B1 (ko) 2016-05-27 2024-08-30 헤마넥스트 인코포레이티드 혐기성 혈액 저장 및 병원체 불활성화 방법
US11260119B2 (en) 2018-08-24 2022-03-01 Pfizer Inc. Escherichia coli compositions and methods thereof
US12138302B2 (en) 2020-10-27 2024-11-12 Pfizer Inc. Escherichia coli compositions and methods thereof
US12357681B2 (en) 2020-12-23 2025-07-15 Pfizer Inc. E. coli FimH mutants and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58135819A (ja) * 1982-02-09 1983-08-12 Nisshin Flour Milling Co Ltd 鶏の大腸菌症の予防法
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
US4702911A (en) 1985-09-27 1987-10-27 Immunomed Corporation Preparation of bacterium pili subunits and vaccines containing pili subunits
ES2060580T3 (es) * 1986-03-11 1994-12-01 Shionogi & Co Adn que tiene una secuencia adn codificante de la proteina flagelina y vector que la contiene.

Also Published As

Publication number Publication date
GR3015782T3 (en) 1995-07-31
US5750115A (en) 1998-05-12
IL95175A (en) 1994-05-30
KR0177510B1 (ko) 1999-03-20
EP0413378A1 (en) 1991-02-20
ES2070266T3 (es) 1995-06-01
CN1062605C (zh) 2001-02-28
AU6109990A (en) 1991-02-21
HU211827A9 (en) 1995-12-28
KR910004209A (ko) 1991-03-28
HU210965B (en) 1995-09-28
TW204353B (OSRAM) 1993-04-21
JP3031561B2 (ja) 2000-04-10
NZ234933A (en) 1992-06-25
EP0413378B1 (en) 1995-01-18
IL95175A0 (en) 1991-06-10
CN1049523A (zh) 1991-02-27
DE69016129D1 (de) 1995-03-02
JPH03184996A (ja) 1991-08-12
HUT59612A (en) 1992-06-29
DK0413378T3 (da) 1995-05-15
CA2022420A1 (en) 1991-02-19
AU635062B2 (en) 1993-03-11
DE69016129T2 (de) 1995-05-24
HU905053D0 (en) 1991-01-28
ZA906100B (en) 1991-05-29

Similar Documents

Publication Publication Date Title
CA2022420C (en) Escherichia coli vaccine
Verstreate et al. Outer membrane proteins of Brucella abortus: isolation and characterization
Beachey et al. Purification and properties of M protein extracted from group A streptococci with pepsin: covalent structure of the amino terminal region of type 24 M antigen
Munson et al. Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates.
AU589114B2 (en) Genetically engineered bacteria useful as a vaccine
CA2040544C (en) Actinobacillus pleuropneumoniae subunit vaccine
Ortiz et al. Immunoblot detection of class-specific humoral immune response to outer membrane proteins isolated from Salmonella typhi in humans with typhoid fever
CN105949287B (zh) 一种a型副鸡禽杆菌免疫保护性抗原及其应用
Haeuw et al. The recombinant Klebsiella pneumoniae outer membrane protein OmpA has carrier properties for conjugated antigenic peptides
KR100492305B1 (ko) 열에 불안정한 엔테로톡신과 콜레라톡신 b 유니트간의 혼성분자 및 구조유전자, 플라즈미드, 면역원성단백질, 백신, 약학적 조성물
US5593679A (en) Poultry vaccine against E. coli air sac inflammation and septicaemia
Tagawa et al. Purification and partial characterization of the major outer membrane protein of Haemophilus somnus
WO1999055875A2 (en) VACCINES CONTAINING RECOMBINANT PILIN AGAINST NEISSERIA GONORRHOEAE OR $i(NEISSERIA MENINGITIDIS)
CA2516661C (en) M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever
US20220160860A1 (en) Pneumococcal surface proteins
Rajeev et al. Bordetella bronchiseptica fimbrial protein-enhanced immunogenicity of a Mannheimia haemolytica leukotoxin fragment
RU2818278C2 (ru) Пневмококковые поверхностные белки
Liu et al. Development and Comparison of a Panel of Modified CS17 Fimbrial Tip Adhesin Proteins as Components for an Adhesin-Based Vaccine against Enterotoxigenic Escherichia coli. Microorganisms. 2021; 9 (8): 1646
Woods et al. Purification and serological characterization of a type-specific antigen of Streptococcus equisimilis
Conceição et al. Protection against Lethal Leptospirosis

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry